As ENDO 2016 winds down and we continue to celebrate the Society’s Centennial throughout the year, we now need to focus on new initiatives for the second century of the Endocrine Society.
Outreach to Congress
Our field faces challenges and pressures coming from multiple directions, from shrinking budgets at the National Institutes of Health to the changing Maintenance of Certification procedures of the American Board of Internal Medicine. To help control our destiny within the broader society, later this month, many of our members will head to Capitol Hill to educate Members of Congress about the many accomplishments of endocrinology in the last century, as well as future opportunities to advance research and clinical care. Our group will include a mix of basic scientists, clinical researchers, and physicians-in-practice to showcase the breadth and depth of our field.
A new journal for the Endocrine Society
The scope and variety of Society activities is too vast to even briefly summarize here, but let me focus on crucial initiatives in two of the anchor activities of the Endocrine Society: its publications and annual scientific meeting. This fall, we will be launching Journal of the Endocrine Society, a new open-access journal. This will be the first new Society-owned journal to be introduced in nearly 30 years. The online journal’s content will span basic science, clinical science, and clinical practice. We are delighted to have Past President J. Larry Jameson, MD, PhD, Executive Vice President of the University of Pennsylvania for the Health System and Dean of the Raymond Ruth Perelman School of Medicine, Perelman Center for Advanced Medicine, at the helm as the journal’s first Editor-in-Chief.
The open-access format clearly is expected to play a big part in the future of scientific publishing, both because of the desire to share new data quickly with the general public and because of fiscal advantages of this model in our paper-free age. While all of our journals are global, this one will have a particular emphasis on having editorial leadership from all over the world to assure vigorous international perspectives at the editorial level. Further, the lack of page constraints will allow the new journal to publish some papers of high quality that cannot fit into the inevitable page limits of our traditional journals. This cooperation among journals will serve our members well and could serve as a model for future collaborative interactions among all the Endocrine Society journals.
Changes at ENDO
The Endocrine Society formed the ENDO Task Force to evaluate ways to continue improving upon our successful annual meeting. The Task Force, led by Vice President (Clinical Scientist) Anthony McCall, MD, PhD, has identified new opportunities to incorporate innovative science into our meeting. One exciting idea is to incorporate the best biologic and medical science with implications for our field, even if it is outside of the field of endocrinology, into the symposia at the annual meeting. While ENDO always has been and continues to be an essential meeting for clinical investigators, we know basic investigators can present their work at many venues. Our goal is to make ENDO the premier meeting for basic endocrine science. With the suggestions of the Endo Task Force in hand, the Annual Meeting Steering Committee, under the leadership of Gary Hammer, MD, PhD, will focus on ways to increase the number of basic scientists who want to submit their abstracts to ENDO. We also will be looking for new ways to harness input from Society members in practice, to guide the Annual Meeting Steering Committee, as they consider novel formats for programs particularly focused on endocrinologists in practice.
The Second Century of the Endocrine Society
Over the next decades, we are likely to see more of today’s exciting developments in basic endocrine science making their way into the clinic. Understanding of the molecular cell biology of endocrine disease will advance, and human studies will take advantage of routine genomic sequencing of individuals and use of personalized stem cells. We should be able to focus on the root causes of the autoimmune diseases and the benign tumors that cause most endocrine disease.
As we move into a new century, the Endocrine Society will be at the forefront of sharing and promoting the science of its members. Start making your plans now to join us next April in Orlando for ENDO 2017. In the meantime, we welcome your guidance on how the Society can provide the richest experience for you.